Calidi Biotherapeutics Inc (AMEX: CLDI) is -91.06% lower on its value in year-to-date trading and has touched a low of $0.73 and a high of $26.30 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLDI stock was last observed hovering at around $1.18 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $1.35, the stock is 23.72% and 20.65% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.81 million and changing 14.42% at the moment leaves the stock -57.93% off its SMA200. CLDI registered -93.08% loss for a year compared to 6-month loss of -31.47%. The firm has a 50-day simple moving average (SMA 50) of $1.11892 and a 200-day simple moving average (SMA200) of $3.20935.
The stock witnessed a 25.00% gain in the last 1 month and extending the period to 3 months gives it a -10.60%, and is 23.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.36% over the week and 16.54% over the month.
Calidi Biotherapeutics Inc (CLDI) has around 41 employees, a market worth around $18.04M and $0.00M in sales. Distance from 52-week low is 84.93% and -94.87% from its 52-week high.
The EPS is expected to grow by 77.06% this year.
Calidi Biotherapeutics Inc (CLDI) Top Institutional Holders
35.0 institutions hold shares in Calidi Biotherapeutics Inc (CLDI), with institutional investors hold 3.00% of the company’s shares. The shares outstanding are 8.08M, and float is at 6.14M with Short Float at 1.81%. Institutions hold 2.45% of the Float.
Calidi Biotherapeutics Inc (CLDI) Insider Activity
#####
